Molecular and biochemical reprogramming of oncogenesis through the activity of prooxidants and antioxidants.
The antioxidant alpha-tocopherol and the weaker antioxidant and prooxidant chemopreventative, beta-carotene have been shown to inhibit tumor cell growth in vivo and in vitro. In some epidemiologic studies their serum levels were demonstrated to be inversely related to the incidence of malignant tumor. We hypothesized two basic pathways triggered by antioxidants and prooxidants, which resulted in the control of tumor cell growth. These included changes in phosphorylation and ultimately transcription. Specifically, the prooxidant beta-carotene treatment produced an oxidative stress resulting in the selective induction of heat shock proteins (hsps). These proteins and other proteins that were possibly oxidized were associated with the increased expression of cyclins (A and D) and increased cdc2 kinase expression. An increase in expression of phosphoproteins, such as p53 (tumor suppressor form) was also discerned. The level of expression for the transcription factor c-fos was reduced. Growth factors that contribute to tumor cell growth were also reduced. Increased DNA fragmentation, depression of proliferation and intracellular calcium levels, the accumulation of tumor cells in G0-->G1, and morphologic changes, were consistent with programmed cell death. Antioxidants such as alpha-tocopherol bound to membrane-associated proteins could inhibit the development of peroxidation products (hydroxyl radicals (.OH)), which attack proteins and modify their function and promote their degradation. Some kinases such as, cdc2 may be increased in activity, which would explain the observed increased expression of tumor suppressor p53, the accumulation of the tumor cells in G1 of the cell cycle and the inhibition of tumor cell proliferation. A reduction in oxidant radicals could also reduce transcription factor products, such as c-myb. Indirectly this result may occur through changes in nuclear translocation (signaling) NF-AT or the Rel-related family of transcription factors, including NF-kB (p50 or p65) or inhibition of immunophilin-calmodulin activity. Although the data remains fragmentary there are common points for control for tumor cell growth resulting from the effects of alpha-tocopherol or beta-carotene treatment. These changes involve phosphorylation and protein expression. Ultimately there is a reduction of important transcription factor protein products, a reduction in response to growth factors, and suppression of cell proliferation, resulting in increased control of the cell cycle.
Department of Oral Pathology and Oral Medicine, Harvard School of Dental Medicine, Boston, Massachusetts 02115.
J L
JL
Schwartz
D Z
DZ
Antoniades
S
S
Zhao
D000818:Animals; D017209:Apoptosis / Q000502:physiology; D016203:CDC2 Protein Kinase / Q000502:physiology; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D002338:Carotenoids / Q000627:therapeutic use*; D002455:Cell Division / Q000187:drug effects / Q000235:genetics; D006224:Cricetinae; D015972:Gene Expression Regulation, Neoplastic; D016158:Genes, p53 / Q000502:physiology; D011905:Genes, ras; D006360:Heat-Shock Proteins / Q000502:physiology; D006801:Humans; D009062:Mouth Neoplasms / Q000188:drug therapy*; D010084:Oxidation-Reduction; D011519:Proto-Oncogenes / Q000502:physiology; D014407:Tumor Cells, Cultured; D014810:Vitamin E / Q000627:therapeutic use*; D019207:beta Carotene
D006360:Heat-Shock Proteins; D019207:beta Carotene; D014810:Vitamin E; D002338:Carotenoids; D016203:CDC2 Protein Kinase